GS MedTech Funding Tracker – Leo Cancer Care, CurifyLabs, and more

From scaling new cancer treatment approaches to expanding personalized medicine and developing smarter diagnostic tools, this week’s MedTech financings show continued investor confidence in technologies addressing major clinical challenges. Here's the rundown. Leo Cancer Care...

GS MedTech Funding Tracker – Leo Cancer Care, CurifyLabs, and more

From scaling new cancer treatment approaches to expanding personalized medicine and developing smarter diagnostic tools, this week’s MedTech financings show continued investor confidence in...

Stereotaxis completes $45M Robocath acquisition to strengthen robotic endovascular platform

Stereotaxis has completed its previously announced acquisition of Robocath in a deal valued at up to $45 million, strengthening its position in the endovascular...

CurifyLabs raises $14M Series A to expand personalized medicine platform

CurifyLabs has raised $14 million in a Series A financing to expand its personalized medicine platform, with proceeds supporting U.S. growth, supply chain expansion,...

Jenscare receives CE mark for LuX-Valve Plus tricuspid valve replacement system

Jenscare Scientific has received CE mark approval under the EU Medical Device Regulation (MDR) for its LuX-Valve Plus transvenous tricuspid valve replacement (TTVR) system,...
[hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

Finance

Funding

Clinical Trials

Nyra Medical enrolls first patient in mitral valve repair early feasibility study

Nyra Medical has enrolled the first patient in its ENHANCE early feasibility study evaluating the investigational CARLEN transcatheter cardiac leaflet enhancer for patients with...

AtaCor enrolls first patient in EV-ICD pivotal study with Abbott

AtaCor Medical has enrolled the first patient in the ALARION-EV pivotal trial evaluating its next-generation extravascular implantable cardioverter-defibrillator (EV-ICD) system, developed in partnership with...

First patient enrolled in study of Reflow Medical’s Spur system

Reflow Medical has enrolled the first patient in the DEEPER CHALLENGE study evaluating its Spur Peripheral Retrievable Scaffold System for below-the-knee treatment in patients...

Francis Medical announces publication of VAPOR 2 pivotal trial results

Francis Medical has published the initial report of its VAPOR 2 pivotal clinical study in The Journal of Urology, showcasing highly positive results for...

Innovation

Regulatory Approvals

GS MedTech Funding Tracker – Leo Cancer Care, CurifyLabs, and more

From scaling new cancer treatment approaches to expanding personalized medicine and developing smarter diagnostic tools, this week’s MedTech financings show continued investor confidence in...

Stereotaxis completes $45M Robocath acquisition to strengthen robotic endovascular platform

Stereotaxis has completed its previously announced acquisition of Robocath in a deal valued at up to $45 million, strengthening its position in the endovascular...

CurifyLabs raises $14M Series A to expand personalized medicine platform

CurifyLabs has raised $14 million in a Series A financing to expand its personalized medicine platform, with proceeds supporting U.S. growth, supply chain expansion,...

Jenscare receives CE mark for LuX-Valve Plus tricuspid valve replacement system

Jenscare Scientific has received CE mark approval under the EU Medical Device Regulation (MDR) for its LuX-Valve Plus transvenous tricuspid valve replacement (TTVR) system,...

M&A

Archives

Latest articles